Belize vs Syrian Arab Republic: Hypertension effective treatment coverage (controlled hypertension)
Belize
21.4%
in 2019
Syrian Arab Republic
20.5%
in 2019
Belize rank
76th
Syrian Arab Republic rank
79th
Hypertension effective treatment coverage (controlled hypertension) over time
- Belize
- Syrian Arab Republic
How they compare
Belize currently reports 21.4% against 20.5% in Syrian Arab Republic, a difference of 0.9%.
Across all 30 years both countries report, Belize has been ahead every year.
Belize ranks 76th and Syrian Arab Republic ranks 79th of 193 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.9% | 5.3% | 1.5% | Belize |
| 2000s | 12.9% | 9.7% | 3.2% | Belize |
| 2010s | 19.5% | 17.9% | 1.6% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Belize or Syrian Arab Republic?
- Belize, at 21.4% against 20.5% in Syrian Arab Republic as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Belize and Syrian Arab Republic?
- 0.9%, with Belize ahead.
- How many years of comparable data are there for Belize and Syrian Arab Republic?
- 30 years are reported by both, from 1990 to 2019.
- How do Belize and Syrian Arab Republic rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Belize ranks 76th and Syrian Arab Republic ranks 79th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.